[Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
Harten
Pontus
P
D017152:Antibodies, Antiphospholipid / Q000276:immunology; D000925:Anticoagulants / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003374:Coumarins / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008137:Longitudinal Studies; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D020945:Lupus Vasculitis, Central Nervous System / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D011247:Pregnancy; D013997:Time Factors
D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D018501:Antirheumatic Agents; D003374:Coumarins; D007166:Immunosuppressive Agents; D006886:Hydroxychloroquine; D003520:Cyclophosphamide; D001379:Azathioprine